About Us

About Us

Kyttaro Therapeutics was incorporated in the US (Delaware corporation) in 2021 to commercialize technologies developed by the founders of Apceth Biopharma GmbH since 2007. The company is headquartered in New York, with research operations in Germany.


Kyttaro Therapeutics was incorporated in the US (Delaware corporation) in 2021 to commercialize technologies developed by the founders of Apceth Biopharma GmbH since 2007. The company is headquartered in New York, with research operations in Germany.
Kyttaro Therapeutics science - New York

Executive Team

nancy j kelley Kyttaro Therapeutics
Nancy J Kelley, JD, MPP
Chief Executive Officer

CEO, Nancy J Kelley + Associates. Founding Executive Director, New York Genome Center. Architect, Launch of OmniSeq, now part of Labcorp Oncology. Co-Founder, Builds Bio+. Co-Founder, GP-write and the Center of Excellence for Engineering Biology. JD/MPP, Harvard Law School/ Kennedy School. BA, Yale University.

manfred stangl md phd Kyttaro Therapeutics
Manfred Stangl, MD, PhD
Chief SCIENTIFIC Officer

Head of Renal and Pancreas Transplant Service, LMU Munich. 25+ years of surgical experience. Recipient of Heinz Maier Leibnitz-Medaille for extraordinary achievements in clinical research. MD, Ludwigs-Maximilians-University (LMU), Munich.

manfred stangl md phd Kyttaro Therapeutics
Eric Hacherl, PhD
Chief OPERATING Officer

Previously, VP, Head of Manufacturing, Spark Therapeutics. Site General Manager and VP Operations, Catalent Gene Therapy. 15 years at Merck, Director, Global Manufacturing Operations, Large Molecule Line. PhD, Chemical Engineering, Rutgers University. MS, Soil and Water Science, University of Florida. BS, University of Delaware.

Scientific Advisory Board

Image
Stephan Grupp, MD, PhD

Stephan Grupp is Section Chief of the Cellular Therapy and Transplant Section, Director of the Cancer Immunotherapy Program, and Medical Director of the Cell and Gene Therapy Laboratory. He holds the Yetta Deitch Novotny Endowed Chair in Pediatric Oncology.  

Image
Gordon Tomaselli, MD

Gordon Tomaselli is the dean at Albert Einstein College of Medicine and executive vice president and chief academic officer at Montefiore Medicine. He is an expert in the fields of sudden cardiac death and arrhythmias. He is the leader of the Hopkins group that is in discussions with Kyttaro around further research with MSC-Klotho for cardiac arrest.

Image
Todd Kilbaugh, MD

Todd Kilbaugh is an anesthesiologist and pediatric intensivist with the Department of Anesthesiology and Critical Care Medicine, medical director of the ECMO Center, and director of the Resuscitation Science Center at Children's Hospital of Philadelphia.

Strategic Advisory Board

Schall_Gary
Gary R. Schall, JD, MBA

Co-Chair, Emerging Company & Venture Capital Practice, WilmerHale. Author & lecturer. JD, Vanderbilt. MBA, St. John’s. BS, Lehigh University.

Ariel Soiffer
Ariel Soiffer, JD

Partner, WilmerHale. Lecturer, Boston University School of Law. Sr. Manager, Diamond Management & Technology Consultants. JD, Boston University. BA Biochemistry, Japanese, U. Penn.

Jennifer Manning
Jennifer Manning, MPA

Chief Commercial Officer, BioCentriq. SVP, Strategic Partnerships, Center for Breakthrough Medicines. Executive Director, Commercial Development FujiFilm and other senior business development roles at Lonza, Pantheon, and Human Genome Sciences. 14 years at Abbvie. MPA, Health Policy and Management, NYU. BA, Biological Sciences, Clemson University.

Luke Buchanan
Luke Buchanan, EPA, PhD

Partner, Hertin and Partner. European Patent Attorney. PhD, Max-Planck Institute for Molecular Cell Biology and Genetics and TU Dresden. BS Biochemistry, Genetics, Molecular Biology, Chemistry, U. of Canterbury, NZ.

Leanne Larson Kyttaro Therapeutics advisory
Leanne Larson, MHA, MPH

Principal, ZS. SVP, Parexel. VP, Outcome Sciences, a Quintiles Company. VP, Sg2. VP, ICON Clinical Research. Senior Health Science Associate, Merck. BS Community Health, U of Illinois, Urbana-Champaign. MPH, U. of Illinois, Chicago. MHA, Governors State University.

Kate McDonough
Kate McDonough, BS

Sr. Associate, Nancy J Kelley + Associates. Enterprise Account Executive, Hive. Scientist, Translational Tissue Engineering Institute, Johns Hopkins. BS Biomedical Engineering, U. Virginia.

Founders

Image
Manfred Stangl, MD, PhD
SCIENTIFIC FOUNDER

Head of Renal and Pancreas Transplant Service, LMU Munich. 25+ years of surgical experience. Recipient of Heinz Maier Leibnitz-Medaille for extraordinary achievements in clinical research. MD, Ludwigs-Maximilians-University (LMU), Munich.

michael strassmair md Kyttar Therapeutics
Michael Strassmair, MD
Co-Founder of JunctuCell (original IP)

Head of Hand Surgery, Starnberg Hospital. 20+ years of surgical experience. Deputy Editor-in-Chief, Springer Journal: Orthopedics and Rheumatism. MD, Ludwigs-Maximilians-University (LMU), Munich.

Image
Nancy J Kelley, JD, MPP
FOUNDER

CEO, Nancy J Kelley + Associates. Founding Executive Director, New York Genome Center. Architect, Launch of OmniSeq, now part of Labcorp Oncology. Co-Founder, Builds Bio+. Co-Founder, GP-write and the Center of Excellence for Engineering Biology. JD/MPP, Harvard Law School/ Kennedy School. BA, Yale University.

Dirk Evers Kyttaro Therapeutics Founder
Dirk J. Evers, PhD
FOUNDER

Head of Data Science and Computer Engineering, Resolve Biosciences GmbH. Managing Partner, Dr. Dirk Evers Consulting. SVP, Molecular Health. SVP, New York Genome Center. Director Computational Biology, Illumina. Executive Director Intl. Grad. School, Bielefeld University. Scientist, Exelixis. PhD, Dipl. Inf., Bielefeld University.

Partner with us

Partner with us




Kyttaro is poised to commence clinical trials in Europe and the US for GvHD applications, with others to follow. We invite interested partners to contact us for more details.

Kyttaro is poised to commence clinical trials in Europe and the US for GvHD applications, with others to follow. We invite interested partners to contact us for more details.

nancy j kelley Kyttaro Therapeutics
Nancy J Kelley, JD, MPP

Chief Executive Officer


manfred stangl md phd Kyttaro Therapeutics
Manfred Stangl, MD, PhD

Head of Renal and Pancreas Transplant Service, LMU Munich


michael strassmair md Kyttaro Therapeutics
Michael Strassmair, MD

Head of Hand Surgery, Starnberg Hospital